MONDAY, SEPTEMBER 26, 2016

Zithromax donations aid in fight against trachoma

Distributions make progress in solving trachoma | Courtesy of biology.usf.edu
A partnership of Pfizer Inc., the International Trachoma Initiative, and the International Coalition for Trachoma Control (ICTC) has donated the 500 millionth dose of Zithromax, or azithromycin, which will help end the suffering of people who have trachoma.

Trachoma is the leading infectious cause of blindness. It makes a patient’s eyelids turn inwards, which causes the eyelashes to rub against the eyeball itself. People with Trachoma have severe pain and develop corneal ulcers and eventually irreversible blindness.

Zithromax tablets are antibiotics that health care workers based in various countries use to treat trachoma. There are currently over 100 non-government, government and private sector partners who are pushing for progress in treating this illness, but there is still much work that needs to be done to reach the goal of eliminating the disease worldwide by 2020.

“This milestone highlights what is possible when partners work together toward a common goal and signifies remarkable achievement in our fight to eliminate trachoma globally,” ICTC Chair Virginia Sarah said. “Our collective efforts are helping to reduce the impacts of this ancient, preventable disease on affected individuals, families and communities.”

Organizations in this story

Pfizer 235 E 42nd St New York, NY 10017-5703

Get notified the next time we write about Pfizer!